Glooko and Companion Medical have announced an integrated data partnership agreement that will enable insulin data from users of the InPen Smart Insulin Injection Pen to be integrated into the Glooko Enterprise diabetes data management system and Glooko Mobile App.
Impact of Integration
The announcement of this integration is significant because InPen is the first “smart” insulin pen to introduce its data integration and compatibility with the Glooko platform
Read More
Impact of Diabetes Management for Patients, Payers, and Providers| News, Policy, Analysis, Insights - HIT Consultant
Glooko Appoints Dr. Mark Clements as Chief Medical Officer
Glooko, a provider of diabetes data management solutions, today announced the appointment of Mark Clements, MD, Ph.D., CPI, FAAP, as Chief Medical Officer. Dr. Clements joins the senior management team of Glooko having served on its medical advisory board since it was formed in 2015 to provide expertise to the organization in the areas of clinical studies and diabetes analytics.
Dr. Clements comes to Glooko from the University of Missouri-Kansas City School of Medicine, where he is Associate
Read More
Solera Health Raises $42M to Scale Integrated Benefit Network for Chronic Disease Prevention
Solera Health, a Phoenix, AZ-based technology-enabled integrated benefit network has raised $42 million in Series C funding led by HCSC Ventures. Current investors BlueCross BlueShield Venture Partners/Sandbox Advantage Fund, Adams Street Partners and SJF Ventures also participated in the most recent funding round. The Series C round, Solera's largest to date, brings its total funding to $72 million.Integrated Benefit NetworkFounded in 2015, Solera Health serves as an integrated benefit network
Read More
Livongo for Diabetes Program Reduced Medical Spending by 22% for Members, Study Finds
The Livongo for Diabetes program delivered a 21.9 percent reduction in medical spending for Livongo members when compared to the matched non-Livongo population, according to study findings published in the latest edition of the Journal of Medical Economics. When taking the average price of the Livongo for Diabetes program into account, the study demonstrated that employers experienced a positive return on investment in one year.Financial Impact of Diabetes Management in the U.S.Diabetes is one
Read More
CHLA Announces 10 Semi-Finalists from Gamifying Pediatrics Hackathon
The Innovation Studio at Children’s Hospital Los Angeles (CHLA), today announced10 semi-finalists from the first ever Gamifying Pediatrics Hackathon, which took place April 12-14, 2019 at BCG Digital Ventures (BCGDV) in Manhattan Beach (CA), the global corporate venture and incubation arm of the Boston Consulting Group. This hackathon brought together 185 enthusiastic participants, including physicians and nurses on the front lines of pediatric medicine, engineers, developers, and experts in
Read More
Livongo Adds HIPAA-Compliant Amazon Alexa Healthcare Skill for Diabetes
Livongo, the leading Applied Health Signals company, today announced the Livongo for Diabetes program will now leverage Amazon Alexa's voice service to offer its Members the ability to ask any of their Alexa-enabled devices to provide their blood glucose readings and health tips via the new Livongo skill. The integration marks Livongo as the first consumer digital health company to collaborate with Amazon Alexa on a new HIPAA-compliant healthcare skill, which builds on Livongo's efforts to make
Read More
Biolinq Lands $4.75M to Expand Biosensor Patch for Continuous Glucose Monitoring
Biolinq, a San Diego, CA-based digital health company developing a minimally-invasive electrochemical biosensor patch for continuous glucose monitoring (CGM) has raised $4.75 million in Series A funding led by the JDRF T1D Fund, Aphelion Capital and LifeSci Venture Partners. Existing investors in the round include M Ventures and Hikma Ventures, the corporate venture capital arm of Hikma Pharmaceuticals. The latest round brings Biolinq’s total Series A funding to $15 million.Inception of
Read More
DarioHealth Integrates Blood Glucose Data with Glytec’s Outpatient Insulin Management Solution
DarioHealth Corp., a blood glucose monitoring system has announced a joint marketing agreement with Glytec, a provider of insulin titration solutions. As part of the partnership, Dario Blood Glucose Monitoring System is now available to hospitals and health systems using Glytec’s virtual insulin titration service for outpatients with diabetes.Integration Details & BenefitsBlood glucose data from the Dario Blood Glucose Monitoring System automatically sent to the Cloud in real-time, will be
Read More
Amazon Choice Integrates with One Drop for Diabetes and Hypertension Management
One Drop, a provider of digital therapeutics solutions, today announced an integration partnership with Amazon’s exclusive health brand, Choice. The integration with One Drop’s app will provide Amazon’s Choice customers living with diabetes and hypertension with affordable, accessible, and comprehensive digital health management services.One Drop/Amazon Choice Integration BenefitsLaunched in late 2018, Amazon Choice was developed by Arcadia Group to offer an array of affordable medical devices
Read More
NHS England Publishes New Guidelines on Flash Glucose Monitors for Type 1 Diabetes Patients
NHS England recently published clinical guidance for flash glucose monitors that outlines funding arrangements for patients with type 1 diabetes and the qualifying criteria to support local health groups. According to NHS England, an estimated 260,000 in England suffer from type 1 diabetes.Starting in April, the NHS will provide the technology for one in five of those with type 1 diabetes in England. Those who qualify include:- People with type 1 diabetes who need intensive monitoring (more than
Read More
